Medindia

X

WuXi PharmaTech to Participate in Upcoming Investor Conferences

Thursday, September 17, 2009 General News J E 4
Advertisement
SHANGHAI, Sept. 10 WuXi PharmaTech (Cayman) Inc.(NYSE: WX) today announced that Dr. Ge Li, the Company's Chairman and ChiefExecutive Officer, will participate at the Morgan Stanley Global HealthcareUnplugged Conference in New York on Tuesday, September 15, 2009, at 11:30 amEastern Daylight Savings Time, and will present at the Bank of America MerrillLynch Global Healthcare Conference in London on Thursday, September 17, 2009,at 11:20 am GMT/6:20 am Eastern Daylight Savings Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The Company will broadcast its participation at the Morgan StanleyConference. The public may access the broadcast through the InvestorRelations section of the Company's web site: http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech provides abroad and integrated portfolio of laboratory and manufacturing servicesthroughout the drug and medical device R&D process. WuXi PharmaTech'sservices are designed to assist its global partners in shortening the cycleand lowering the cost of drug and medical device R&D. WuXi PharmaTech'soperating subsidiaries are known as WuXi AppTec. For more information, pleasevisit: http://www.wuxiapptec.com .For more information, please contact: Ronald Aldridge Director of Investor Relations WuXi PharmaTech (Cayman) Inc. Tel: +1-201-585-2048 Email: Ron_Aldridge@wuxiapptec.com Web: http://www.wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Johnson & Johnson Honors 2009 Recipient of The Dr....
S
QIAGEN's New Product Line, QIAsafe(R) DNA Blood, h...